Abstract

Detection of dysplasia and early-stage carcinoma of the lower gastrointestinal tract is important in the prevention and curative treatment of cancer. Fluorescence-based endoscopic imaging and spectrometry promise a supplemental technique for conventional endoscopy. Fluorescence diagnosis is characterized by the stimulation of exogenous or endogenous fluorophores in malignant or precancerous tumor cells. The emitted fluorescence allows the identification of lesions that are otherwise occult in conventional endoscopy. A review of literature was performed to examine the experience gained with fluorescence diagnosis and to assess its clinical value in the detection of colorectal diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.